RESUMO
Central kisspeptin action is well known in reproductive regulation; however, its peripheral action is not well understood. This study aimed to 1) compare serum or cerebrospinal fluid (CSF) kisspeptin levels between different body mass index (BMI) groups 2) compare the levels of kisspeptin between serum and CSF, and 3) determine correlations between serum or CSF kisspeptin levels with clinical, metabolic, and reproductive parameters. There were 40 male subjects undergoing operations with lumbar puncture anesthesia. Subgroup analysis was performed to compare between the normal (n = 12), overweight (n = 10), and obese groups (n = 17). One lean subject was recruited for correlation analysis. Serum kisspeptin levels were significantly higher in the obese group when compared to the normal weight and overweight groups even after adjusting for age or diastolic blood pressure (DBP) (p < 0.05 all). Serum leptin levels were significantly higher in the obese group when compared to the normal weight and overweight groups (p < 0.05 all). CSF kisspeptin levels were below the minimum detectable concentration for the assay (<0.06 ng/mL). Serum kisspeptin was positively correlated with body weight, BMI, plasma insulin, the homeostatic model assessment for insulin resistance (HOMA-IR), and serum leptin but was negatively correlated with plasma LH (p < 0.05 all). In conclusion, serum kisspeptin was related to obesity, leptin, insulin, and insulin resistance, while CSF kisspeptin was below the limits of detection. Thus, peripheral kisspeptin might have a role in metabolic regulation.
Assuntos
Kisspeptinas/sangue , Kisspeptinas/líquido cefalorraquidiano , Leptina/sangue , Obesidade/genética , Reprodução/genética , Adulto , Anestesia , Índice de Massa Corporal , Peso Corporal/genética , Feminino , Humanos , Resistência à Insulina/genética , Kisspeptinas/genética , Leptina/genética , Masculino , Obesidade/sangue , Obesidade/líquido cefalorraquidiano , Obesidade/patologia , Sobrepeso/sangue , Sobrepeso/líquido cefalorraquidiano , Sobrepeso/genética , Sobrepeso/patologia , Punção Espinal/métodosRESUMO
OBJECTIVE: In this study, we assess the impact of obesity and diabetes on maternal brain and periphery, as well as fetal exposure to insulin and leptin, and two hormones that play an important role in regulating energy homeostasis. STUDY DESIGN: Fasting maternal plasma, fetal cord vein and artery plasma, and maternal cerebrospinal fluid (CSF) were collected in 37 women (12 lean, nondiabetic [prepregnancy body mass index (BMI): 22.9 ± 1.7 kg/m2]; 12 overweight/obese nondiabetic [BMI: 37.8 ± 7.3 kg/m2]; 13 gestational/type 2 diabetes mellitus [BMI: 29.8 ± 7.3 kg/m2]) with uncomplicated singleton pregnancies undergoing elective Cesarean delivery. HbA1C, insulin, glucose, and leptin levels were measured. RESULTS: Compared with lean mothers, mothers with obesity and diabetes mellitus (DM) had significantly lower CSF-to-plasma ratios of insulin. Moreover, mothers with obesity and DM had significantly lower cord arterial and cord venous to maternal plasma ratios of insulin, but not leptin, compared with lean mothers. There were no differences in CSF and cord blood insulin and leptin levels between obese and DM mothers. CONCLUSION: Compared with lean individuals, mothers with obesity and DM have relative deficiencies in insulin exposure. The patterns observed in mothers with obesity and diabetes were similar highlighting the importance of the maternal metabolic environment in obesity and suggesting obese patients warrant further clinical focus.
Assuntos
Diabetes Gestacional/metabolismo , Insulina/metabolismo , Leptina/metabolismo , Obesidade/metabolismo , Adulto , Peso ao Nascer , Glicemia/metabolismo , Índice de Massa Corporal , Diabetes Gestacional/sangue , Diabetes Gestacional/líquido cefalorraquidiano , Feminino , Sangue Fetal/metabolismo , Hemoglobinas Glicadas/metabolismo , Humanos , Recém-Nascido , Obesidade/sangue , Obesidade/líquido cefalorraquidiano , Gravidez , Complicações na GravidezRESUMO
Obesity has been associated with cognitive decline, atrophy of brain regions related to learning and memory, and higher risk of developing dementia. However, the molecular mechanisms underlying these neurological alterations are still largely unknown. Here, we investigate the effects of palmitate, a saturated fatty acid present at high amounts in fat-rich diets, in the brain. Palmitate is increased in the cerebrospinal fluid (CSF) of overweight and obese patients with amnestic mild cognitive impairment. In mice, intracerebroventricular infusion of palmitate impairs synaptic plasticity and memory. Palmitate induces astroglial and microglial activation in the mouse hippocampus, and its deleterious impact is mediated by microglia-derived tumor necrosis factor alpha (TNF-α) signaling. Our results establish that obesity is associated with increases in CSF palmitate. By defining a pro-inflammatory mechanism by which abnormal levels of palmitate in the brain impair memory, the results further suggest that anti-inflammatory strategies may attenuate memory impairment in obesity.
Assuntos
Transtornos da Memória/etiologia , Obesidade/líquido cefalorraquidiano , Palmitatos/líquido cefalorraquidiano , Fator de Necrose Tumoral alfa/metabolismo , Animais , Humanos , Transtornos da Memória/patologia , Camundongos , Obesidade/patologiaRESUMO
Obesity and metabolic syndrome are threats to the health of large population worldwide as they are associated with high mortality, mainly linked to cardiovascular diseases. Recently, CPN-116 (CPN), which is an agonist peptide specific to neuromedin-U receptor 2 (NMUR2) that is expressed predominantly in the brain, has been developed as a new therapeutic candidate for the treatment of obesity and metabolic syndrome. However, treatment with CPN poses a challenge due to the limited delivery of CPN to the brain. Recent studies have clarified that the direct anatomical connection of the nasal cavity with brain allows delivery of several drugs to the brain. In this study, we confirm the nasal cavity as a promising CPN delivery route to the brain for the treatment of obesity and metabolic syndrome. According to the pharmacokinetic study, the clearance of CPN from the blood was very rapid with a half-life of 3 min. In vitro study on its stability in the serum and cerebrospinal fluid (CSF) indicates that CPN was more stable in the CSF than in the blood. The concentration of CPN in the brain was higher after nasal administration, despite its lower concentrations in the plasma than that after intravenous administration. The study on its pharmacological potency suggests the effective suppression of increased body weight in mice in a dose-dependent manner due to the direct activation of NMUR2 by CPN. This results from the higher concentration of corticosterone in blood after nasal administration of CPN as compared to nasal application of saline. In conclusion, the above findings indicate that the nasal cavity is a promising CPN delivery route to the brain to treat obesity and metabolic syndrome.
Assuntos
Fármacos Antiobesidade/administração & dosagem , Encéfalo/efeitos dos fármacos , Obesidade/tratamento farmacológico , Peptídeos/administração & dosagem , Receptores de Neurotransmissores/agonistas , Administração Intranasal , Animais , Fármacos Antiobesidade/sangue , Fármacos Antiobesidade/líquido cefalorraquidiano , Fármacos Antiobesidade/farmacocinética , Corticosterona/sangue , Células HEK293 , Humanos , Camundongos , Obesidade/sangue , Obesidade/líquido cefalorraquidiano , Peptídeos/sangue , Peptídeos/líquido cefalorraquidiano , Peptídeos/farmacocinética , Ratos , Ratos WistarRESUMO
PURPOSE OF REVIEW: This article summarizes recent advances in the identification of genetic and environmental factors that affect the risk of developing multiple sclerosis (MS) and the pathogenic processes involved in acute relapses and relapse-independent disability progression. RECENT FINDINGS: The number of single-nucleotide polymorphisms associated with increased risk of MS has increased to more than 200 variants. The evidence for the association of Epstein-Barr virus infection, vitamin D deficiency, obesity, and smoking with increased risk of MS has further accumulated, and, in cases of obesity and vitamin D deficiency, the evidence for causal association has strengthened. Interactions between genetic and environmental factors have been studied more extensively. Dietary factors and changes in the gut microbiota are emerging as possible modulators of the disease risk. Several processes important to MS pathogenesis have been newly investigated or investigated more comprehensively, including the role of B cells, innate immune cells, meningeal inflammation, cortical and gray matter demyelination, and early axonal and neuronal loss. SUMMARY: MS is a complex disease in which the interaction between genetic and environmental factors causes a cascade of events, including activation of the adaptive and innate immune system, blood-brain barrier breakdown, central nervous system demyelination, and axonal and neuronal damage with variable degrees of repair. These events manifest as potentially reversible focal neurologic symptoms or progressive nonremitting physical and cognitive disability, or both. Advances in the understanding of the risk factors and pathogenic mechanisms of MS have resulted in improved therapeutic strategies. The results of ongoing or future studies are needed to successfully and fully translate these advances into clinical practice.
Assuntos
Infecções por Vírus Epstein-Barr/diagnóstico , Esclerose Múltipla Recidivante-Remitente/líquido cefalorraquidiano , Esclerose Múltipla Recidivante-Remitente/diagnóstico por imagem , Obesidade/diagnóstico , Deficiência de Vitamina D/diagnóstico , Adulto , Progressão da Doença , Infecções por Vírus Epstein-Barr/líquido cefalorraquidiano , Infecções por Vírus Epstein-Barr/genética , Feminino , Humanos , Esclerose Múltipla/líquido cefalorraquidiano , Esclerose Múltipla/diagnóstico por imagem , Esclerose Múltipla/genética , Esclerose Múltipla Recidivante-Remitente/genética , Obesidade/líquido cefalorraquidiano , Obesidade/genética , Fatores de Risco , Deficiência de Vitamina D/líquido cefalorraquidiano , Deficiência de Vitamina D/genéticaRESUMO
The hypothalamic neuropeptide orexin A (hypocretin-1) is a key signal in sleep/wake regulation and promotes food intake. We investigated the relationship between cerebrospinal fluid orexin A concentrations and body composition in non-narcoleptic human subjects with a wide range of body weight to gain insight into the role of orexin A in human metabolism. We collected cerebrospinal fluid and blood samples and measured body composition by bioelectric impedance analysis in 36 subjects (16 women and 20 men) with body mass indices between 16.24 and 38.10â¯kg/m2 and an age range of 19-80 years. Bivariate Pearson correlations and stepwise multiple regressions were calculated to determine associations between orexin A and body composition as well as biometric variables. Concentrations of orexin A in cerebrospinal fluid averaged 315.6⯱â¯6.0â¯pg/ml, were comparable between sexes (pâ¯>â¯0.15) and unrelated to age (pâ¯>â¯0.66); they appeared slightly reduced in overweight/obese compared to normal-weight subjects (pâ¯=â¯.07). Orexin A concentrations decreased with body weight (râ¯=â¯-0.38, pâ¯=â¯.0229) and fat-free mass (râ¯=â¯-0.39, pâ¯=â¯.0173) but were not linked to body fat mass (pâ¯>â¯0.24). They were inversely related to total body water (râ¯=â¯-0.39, pâ¯=â¯.0174) as well as intracellular (râ¯=â¯-0.41, pâ¯=â¯.0139) and extracellular water (râ¯=â¯-0.35, pâ¯=â¯.0341). Intracellular water was the only factor independently associated with cerebrospinal fluid orexin A concentrations (pâ¯=â¯.0139). We conclude that cerebrospinal fluid orexin A concentrations do not display associations with body adiposity, but are inversely related to intracellular water content. These cross-sectional findings suggest a link between orexin A signaling and the regulation of water homeostasis in humans.
Assuntos
Composição Corporal/fisiologia , Neuropeptídeos/líquido cefalorraquidiano , Obesidade/líquido cefalorraquidiano , Orexinas/líquido cefalorraquidiano , Tecido Adiposo/metabolismo , Tecido Adiposo/fisiopatologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Índice de Massa Corporal , Ingestão de Alimentos/fisiologia , Feminino , Humanos , Hipotálamo/metabolismo , Masculino , Pessoa de Meia-Idade , Neuropeptídeos/sangue , Obesidade/sangue , Obesidade/fisiopatologia , Orexinas/sangue , Sono/fisiologia , Água/metabolismoRESUMO
BACKGROUND: Epidemiological studies proposed a linear connection between developing dementia including Alzheimer's disease (AD) and obesity. Adiposity, insulin resistance and dementia indicated probable mechanistic links in this process. Indeed, it has been known that optimum insulin action in the brain plays critical role in cognitive function; whereas, insulin resistance in obese individuals finally leads to insulin deficiency in central nervous system (CNS) and down regulation of the efficiency of insulin uptake from periphery into CSF. In the current study, we aimed to assess correlation between increased body weight and insulin resistance with CSF to serum ratio of insulin and to evaluate the correlation between CSF to serum ratio of insulin with cognitive function in high fat diet induced obese rats. METHODS AND MATERIAL: Twelve male Wister rats were randomly divided into two groups receiving Diet 1 (D1, 10% fat) and Diet 2 (D2, 59% fat) for 16 weeks. Weight was recorded weekly to assure body weight gain. Morris Water Maze (MWM) task was designed to assess spatial learning memory function. Finally, blood samples were collected for determining fasting serum glucose using enzymatic spectrophotometric method, insulin levels by ELISA kit and homeostasis model assessment of insulin resistance (HOMA-IR) were calculated. Fasting Cerebrospinal Fluid (CSF) insulin was also measured by ELISA kit. RESULT: D1 and D 2 groups both experienced weight gain but weight gain in D2 group were significantly higher. A significant correlation between CSF to serum ratio of insulin with weight (r=0.882, p=0.001) and HOMA-IR index (r=0.798, p=0.002) was reported. Moreover, the present study indicated significant correlations between CSF to serum ratio of insulin and escape latency time in first (r=0.631, p=0.028), second (r=0.716, p=0.009) and third (r=0.609, p=0.036) day of MWM test and probe time of MWM test (r=0.762, p=0.004). CONCLUSION: Increased body weight induced by high fat diet and insulin resistance in rats led to down regulation of CSF to serum ratio of insulin in the current research. Brain insulin deficiency may be responsible for possible decline of cognitive function in obesity. More researches are needed to better clarify the underlying mechanisms and also to confirm the similar findings in human studies.
Assuntos
Transtornos Cognitivos/etiologia , Insulina/deficiência , Obesidade/complicações , Animais , Transtornos Cognitivos/sangue , Transtornos Cognitivos/líquido cefalorraquidiano , Dieta Hiperlipídica/efeitos adversos , Ingestão de Alimentos/fisiologia , Insulina/sangue , Insulina/líquido cefalorraquidiano , Resistência à Insulina , Masculino , Aprendizagem em Labirinto/fisiologia , Obesidade/sangue , Obesidade/líquido cefalorraquidiano , Obesidade/etiologia , Distribuição Aleatória , Ratos , Ratos Wistar , Estatística como Assunto , Fatores de TempoRESUMO
The melanocortin neuronal system, which consists of hypothalamic proopiomelanocortin (POMC) and agouti-related protein (AgRP) neurons, is a leptin target that regulates energy balance and metabolism, but studies in humans are limited by a lack of reliable biomarkers to assess brain melanocortin activity. The objective of this study was to measure the POMC prohormone and its processed peptide, ß-endorphin (ß-EP), in cerebrospinal fluid (CSF) and AgRP in CSF and plasma after calorie restriction to validate their utility as biomarkers of brain melanocortin activity. CSF and plasma were obtained from 10 lean and obese subjects after fasting (40 h) and refeeding (24 h), and from 8 obese subjects before and after 6 wk of dieting (800 kcal/day) to assess changes in neuropeptide and hormone levels. After fasting, plasma leptin decreased to 35%, and AgRP increased to 153% of baseline. During refeeding, AgRP declined as leptin increased; CSF ß-EP increased, but POMC did not change. Relative changes in plasma and CSF leptin were blunted in obese subjects. After dieting, plasma and CSF leptin decreased to 46% and 70% of baseline, CSF POMC and ß-EP decreased, and plasma AgRP increased. At baseline, AgRP correlated negatively with insulin and homeostasis model assessment (HOMA-IR), and positively with the Matsuda index. Thus, following chronic calorie restriction, POMC and ß-EP declined in CSF, whereas acutely, only ß-EP changed. Plasma AgRP, however, increased after both acute and chronic calorie restriction. These results support the use of CSF POMC and plasma AgRP as biomarkers of hypothalamic melanocortin activity and provide evidence linking AgRP to insulin sensitivity.
Assuntos
Proteína Relacionada com Agouti/líquido cefalorraquidiano , Encéfalo/metabolismo , Restrição Calórica , Insulina/sangue , Leptina/líquido cefalorraquidiano , Obesidade/líquido cefalorraquidiano , Pró-Opiomelanocortina/líquido cefalorraquidiano , beta-Endorfina/líquido cefalorraquidiano , Adulto , Proteína Relacionada com Agouti/sangue , Estudos de Casos e Controles , Ensaio de Imunoadsorção Enzimática , Jejum/sangue , Jejum/líquido cefalorraquidiano , Feminino , Humanos , Resistência à Insulina , Leptina/sangue , Masculino , Melanocortinas/metabolismo , Pessoa de Meia-Idade , Obesidade/sangue , Pró-Opiomelanocortina/sangue , Radioimunoensaio , Adulto Jovem , beta-Endorfina/sangueRESUMO
OBJECTIVE: During pregnancy, metabolic interactions must be adapted, though neuroendocrine mechanisms for increased food intake are poorly understood. The objective of this study was to characterize differences in insulin, leptin, and agouti-related protein (AgRP) levels in serum and cerebrospinal fluid (CSF) in pregnant women with normal weight (NW) and pregnant women with overweight (OW) or obesity (OB). Placenta as a source for increased peripheral AgRP levels during pregnancy was also investigated. METHODS: Women were recruited at admission for elective cesarean section. Insulin, AgRP, and leptin were measured in serum and CSF from 30 NW, 25 OW, and 21 OB at term. Serum during pregnancy and placenta at term were collected for further AgRP analysis. RESULTS: Immunohistology showed placental production of AgRP and serum AgRP levels increased throughout pregnancy. CSF AgRP, leptin, and insulin levels were higher in OW and OB than NW. Serum leptin and insulin levels were higher and AgRP lower in OB than NW. CONCLUSIONS: High serum AgRP levels might protect from the suppressive effects of leptin during pregnancy. Pregnant women with OB and OW might further be protected from the suppressive effect of leptin by high CSF AgRP levels. Evidence was found, for the first time, of human placental AgRP production mirrored by levels in the circulation.
Assuntos
Proteína Relacionada com Agouti/líquido cefalorraquidiano , Índice de Massa Corporal , Insulina/líquido cefalorraquidiano , Leptina/líquido cefalorraquidiano , Gravidez , Adulto , Proteína Relacionada com Agouti/sangue , Ingestão de Energia , Feminino , Humanos , Insulina/sangue , Leptina/sangue , Obesidade/sangue , Obesidade/líquido cefalorraquidiano , Sobrepeso/sangue , Sobrepeso/líquido cefalorraquidiano , Placenta/metabolismo , Estudos Prospectivos , Aumento de PesoAssuntos
Depressão/complicações , Depressão/tratamento farmacológico , Obesidade/complicações , Obesidade/psicologia , Fator de Transcrição STAT3/antagonistas & inibidores , Depressão/líquido cefalorraquidiano , Depressão/psicologia , Humanos , Interleucina-6/líquido cefalorraquidiano , Obesidade/líquido cefalorraquidiano , Serotonina/metabolismoRESUMO
Prader-Willi syndrome is a congenital neurodevelopmental disorder resulting from deletion of the paternal copies of genes within the chromosome region 15q11-q13. Patients with Prader-Willi syndrome often exhibit excessive daytime sleepiness, excessive appetite, and obesity. As is the case in narcolepsy, orexin (hypocretin) may be responsible for these symptoms. However, reports showing cerebrospinal fluid orexin levels in Prader-Willi syndrome patients have been limited. The aim of this study was to examine the relationship between the characteristic symptoms of Prader-Willi syndrome and cerebrospinal fluid orexin levels. We clinically identified 14 Prader-Willi syndrome patients and examined their cerebrospinal fluid orexin levels. A total of 12 patients with a 15q11-q13 deletion and two patients with maternal uniparental disomy of chromosome 15 were identified. A total of 37 narcoleptic patients and 14 idiopathic hypersomnia patients were recruited for comparison. Cerebrospinal fluid orexin levels (median [25-75 percentiles]) in the 14 Prader-Willi syndrome patients were intermediate (192 [161-234.5] pg/ml), higher than in the narcoleptic patients, but lower than in the idiopathic hypersomnia patients. Body mass index of the Prader-Willi syndrome patients was higher than in the narcoleptic and idiopathic hypersomnia patients. There was also a negative correlation between Epworth sleepiness scale scores and orexin levels in Prader-Willi syndrome patients. Decreased cerebrospinal fluid orexin levels in Prader-Willi syndrome may play an important role in severity of obesity and excessive daytime sleepiness.
Assuntos
Hipersonia Idiopática/líquido cefalorraquidiano , Narcolepsia/líquido cefalorraquidiano , Orexinas/líquido cefalorraquidiano , Síndrome de Prader-Willi/líquido cefalorraquidiano , Adolescente , Adulto , Criança , Deleção Cromossômica , Cromossomos Humanos Par 15/genética , Feminino , Humanos , Hipersonia Idiopática/genética , Hipersonia Idiopática/fisiopatologia , Masculino , Narcolepsia/genética , Narcolepsia/fisiopatologia , Obesidade/líquido cefalorraquidiano , Obesidade/genética , Obesidade/fisiopatologia , Orexinas/genética , Síndrome de Prader-Willi/genética , Síndrome de Prader-Willi/fisiopatologiaRESUMO
Leptin and its neuronal targets, which produce proopiomelanocortin (POMC) and agouti-related protein (AgRP), regulate energy balance. This study characterized leptin, POMC, and AgRP in the cerebrospinal fluid (CSF) of 47 healthy human subjects, 23 lean and 24 overweight/obese (OW/OB), as related to BMI, adiposity, plasma leptin, soluble leptin receptor (s-OB-R), and insulin. POMC was measured since the POMC prohormone is the predominant POMC peptide in CSF and correlates with hypothalamic POMC in rodents. Plasma AgRP was similarly characterized. CSF leptin was 83-fold lower than in plasma and correlated strongly with BMI, body fat, and insulin. The relative amount of leptin transported into CSF declined with increasing BMI, ranging from 4.5 to 0.52%, consistent with a saturable transport mechanism. CSF sOB-R was 78-fold lower than in plasma and correlated negatively with plasma and CSF leptin. CSF POMC was higher in lean vs. OW/OB subjects (P < 0.001) and correlated negatively with CSF leptin (r = -0.60, P < 0.001) and with plasma leptin, insulin, BMI, and adiposity. CSF AgRP was not different in lean vs. OW/OB; however, plasma AgRP was higher in lean subjects (P = 0.001) and correlated negatively with BMI, adiposity, leptin, insulin, and HOMA (P < 0.005). Thus, CSF measurements may provide useful biomarkers for brain leptin and POMC activity. The striking negative correlation between CSF leptin and POMC could be secondary to leptin resistance and/or neuronal changes associated with obesity but may also indicate that POMC plays a primary role in regulating body weight and adiposity. The role of plasma AgRP as a neuroendocrine biomarker deserves further study.
Assuntos
Adiposidade , Proteína Relacionada com Agouti/líquido cefalorraquidiano , Leptina/líquido cefalorraquidiano , Obesidade/líquido cefalorraquidiano , Pró-Opiomelanocortina/líquido cefalorraquidiano , Adulto , Proteína Relacionada com Agouti/sangue , Índice de Massa Corporal , Feminino , Humanos , Insulina/sangue , Leptina/sangue , Masculino , Pessoa de Meia-Idade , Sobrepeso/líquido cefalorraquidiano , Receptores para Leptina/sangue , Adulto JovemRESUMO
Obesity has a significant effect on the cephalic spread of a spinal block (SB) due to a reduction in cerebrospinal fluid (CSF). SB is controlled by the tissue blood flow in addition to the CSF. Some positions and techniques of surgery used can cause changes in hemodynamics. We investigated effects of hemodynamic changes that may occur during Transurethral prostate resection (TUR-P) and lithotomy position (LP) at the SB level in obese versus nonobese individuals. Sixty patients who had undergone TUR-P operation under spinal anesthesia were divided into a nonobese (BMI < 25 kg/m(2), Group N) or obese (BMI ≥ 30 kg/m(2), Group O) group. SB assessments were recorded afterthe LP. SB at 6 and 120 min and the peak SB level were compared between two groups. Hemodynamics were recorded after LP. Peak and 6 min SB levels were similar between the groups, while 120 min SB levels were significantly higher for Group O (P < 0.05). Blood pressure (BP) after the LP was significantly higher for Group N (P < 0.05). LP and TUR-P increased the BP in Group N when compared to Group O. The increase in hemodynamics enhances the blood flow in the spinal cord and may form similar SB levels in nonobese patients to those in obese patients. However, SB time may be longer in obese patients.
Assuntos
Raquianestesia , Hemodinâmica , Obesidade/complicações , Ressecção Transuretral da Próstata , Idoso , Bupivacaína/administração & dosagem , Humanos , Masculino , Pessoa de Meia-Idade , Obesidade/líquido cefalorraquidiano , Obesidade/fisiopatologia , Decúbito DorsalRESUMO
BACKGROUND: Fructose, unlike glucose, promotes feeding behavior in rodents and its ingestion exerts differential effects in the human brain. However, plasma fructose is typically 1/1000 th of glucose levels and it is unclear to what extent fructose crosses the blood-brain barrier. We investigated whether local endogenous central nervous system (CNS) fructose production from glucose via the polyol pathway (glucose â sorbitol â fructose) contributes to brain exposure to fructose. METHODS: In this observational study, fasting glucose, sorbitol and fructose concentrations were measured using gas-chromatography-liquid mass spectroscopy in cerebrospinal fluid (CSF), maternal plasma, and venous cord blood collected from 25 pregnant women (6 lean, 10 overweight/obese, and 9 T2DM/gestational DM) undergoing spinal anesthesia and elective cesarean section. RESULTS: As expected, CSF glucose was ~ 60% of plasma glucose levels. In contrast, fructose was nearly 20-fold higher in CSF than in plasma (p < 0.001), and CSF sorbitol was ~ 9-times higher than plasma levels (p < 0.001). Moreover, CSF fructose correlated positively with CSF glucose (ρ 0.45, p = 0.02) and sorbitol levels (ρ 0.75, p < 0.001). Cord blood sorbitol was also ~ 7-fold higher than maternal plasma sorbitol levels (p = 0.001). There were no differences in plasma, CSF, and cord blood glucose, fructose, or sorbitol levels between groups. CONCLUSIONS: These data raise the possibility that fructose may be produced endogenously in the human brain and that the effects of fructose in the human brain and placenta may extend beyond its dietary consumption.
Assuntos
Biomarcadores/sangue , Biomarcadores/líquido cefalorraquidiano , Glicemia/análise , Frutose/sangue , Frutose/líquido cefalorraquidiano , Plasma/química , Sorbitol/análise , Adulto , Diabetes Mellitus Tipo 2/sangue , Diabetes Mellitus Tipo 2/líquido cefalorraquidiano , Diabetes Mellitus Tipo 2/patologia , Diabetes Gestacional/sangue , Diabetes Gestacional/líquido cefalorraquidiano , Diabetes Gestacional/patologia , Feminino , Cromatografia Gasosa-Espectrometria de Massas/métodos , Humanos , Obesidade/sangue , Obesidade/líquido cefalorraquidiano , Obesidade/patologia , Sobrepeso/sangue , Sobrepeso/líquido cefalorraquidiano , Sobrepeso/patologia , Gravidez , Magreza/sangue , Magreza/líquido cefalorraquidiano , Magreza/patologiaRESUMO
BACKGROUND: There is compelling evidence in humans that peripheral endocannabinoid signaling is disrupted in obesity. However, little is known about the corresponding central signaling. Here, we have investigated the relationship between gender, leptin, body mass index (BMI) and levels of the endocannabinoids anandamide (AEA) and 2-arachidonoylglycerol (2-AG) in the serum and cerebrospinal fluid (CSF) of primarily overweight to obese patients with osteoarthritis. METHODOLOGY/PRINCIPAL FINDINGS: Patients (20 females, 15 males, age range 44-78 years, BMI range 24-42) undergoing total knee arthroplasty for end-stage osteoarthritis were recruited for the study. Endocannabinoids were quantified by liquid chromatography - mass spectrometry. AEA and 2-AG levels in the serum and CSF did not correlate with either age or BMI. However, 2-AG levels in the CSF, but not serum, correlated negatively with CSF leptin levels (Spearman's ρ -0.48, P=0.0076, n=30). No such correlations were observed for AEA and leptin. CONCLUSIONS/SIGNIFICANCE: In the patient sample investigated, there is a negative association between 2-AG and leptin levels in the CSF. This is consistent with pre-clinical studies in animals, demonstrating that leptin controls the levels of hypothalamic endocannabinoids that regulate feeding behavior.
Assuntos
Endocanabinoides/sangue , Endocanabinoides/líquido cefalorraquidiano , Leptina/sangue , Osteoartrite/sangue , Osteoartrite/líquido cefalorraquidiano , Adulto , Idoso , Ácidos Araquidônicos/sangue , Ácidos Araquidônicos/líquido cefalorraquidiano , Artroplastia do Joelho , Índice de Massa Corporal , Cromatografia Líquida , Feminino , Glicerídeos/sangue , Glicerídeos/líquido cefalorraquidiano , Humanos , Masculino , Espectrometria de Massas , Pessoa de Meia-Idade , Obesidade/sangue , Obesidade/líquido cefalorraquidiano , Osteoartrite/cirurgia , Alcamidas Poli-Insaturadas/sangue , Alcamidas Poli-Insaturadas/líquido cefalorraquidianoRESUMO
BACKGROUND: Serotonin (5-hydroxytryptamine, 5HT) is involved in hypothalamic regulation of energy consumption. Also, the gut microbiome can influence neuronal signaling to the brain through vagal afferent neurons. Therefore, serotonin concentrations in the central nervous system and the composition of the microbiota can be related to obesity. OBJECTIVE: To examine adipokine, and, serotonin concentrations, and the gut microbiota in lean dogs and dogs with experimentally induced obesity. ANIMALS: Fourteen healthy Beagle dogs were used in this study. METHODS: Seven Beagle dogs in the obese group were fed commercial food ad libitum, over a period of 6 months to increase their weight and seven Beagle dogs in lean group were fed a restricted amount of the same diet to maintain optimal body condition over a period of 6 months. Peripheral leptin, adiponectin, 5HT, and cerebrospinal fluid (CSF-5HT) levels were measured by ELISA. Fecal samples were collected in lean and obese groups 6 months after obesity was induced. Targeted pyrosequencing of the 16S rRNA gene was performed using a Genome Sequencer FLX plus system. RESULTS: Leptin concentrations were higher in the obese group (1.98 ± 1.00) compared to those of the lean group (1.12 ± 0.07, P = .025). Adiponectin and 5-hydroytryptamine of cerebrospinal fluid (CSF-5HT) concentrations were higher in the lean group (27.1 ± 7.28) than in the obese group (14.4 ± 5.40, P = .018). Analysis of the microbiome revealed that the diversity of the microbial community was lower in the obese group. Microbes from the phylum Firmicutes (85%) were predominant group in the gut microbiota of lean dogs. However, bacteria from the phylum Proteobacteria (76%) were the predominant group in the gut microbiota of dogs in the obese group. CONCLUSIONS AND CLINICAL IMPORTANCE: Decreased 5HT levels in obese group might increase the risk of obesity because of increased appetite. Microflora enriched with gram-negative might be related with chronic inflammation status in obese dogs.
Assuntos
Adiponectina/sangue , Doenças do Cão/sangue , Fezes/microbiologia , Leptina/sangue , Obesidade/veterinária , Serotonina/sangue , Animais , Doenças do Cão/líquido cefalorraquidiano , Doenças do Cão/microbiologia , Cães , Ensaio de Imunoadsorção Enzimática , Obesidade/sangue , Obesidade/líquido cefalorraquidiano , Obesidade/microbiologiaRESUMO
Peripheral action of irisin improves glucose homeostasis and increases energy expenditure, with no data on a central role of irisin in metabolism. These studies sought to examine 1) presence of irisin in human cerebrospinal fluid (CSF) and banked human hypothalamic tissue, 2) serum irisin in maternal subjects across varying adiposities with or without gestational diabetes (GDM), and 3) their respective neonate offspring. CSF, serum, and neonatal cord serum were collected from 91 pregnant women with and without GDM attending for an elective cesarean section [body mass index (BMI): 37.7 ± 7.6 kg/m(2); age: 32 ± 8.3 yr]. Irisin was assessed by ELISA and correlated with biochemical and anthropometric data. Irisin expression was examined in human hypothalamus by immunohistochemical staining. Serum irisin in pregnant women was significantly lower in nonobese compared with obese and GDM subjects, after adjusting for BMI, lipids, and glucose. Irisin was present in neonatal cord serum (237 ± 8 ng/ml) and maternal CSF (32 ± 1.5 ng/ml). CSF irisin correlated positively with serum irisin levels from nonobese and obese pregnant women (P < 0.01), with CSF irisin significantly raised in GDM subjects (P < 0.05). Irisin was present in human hypothalamic sections in the paraventricular neurons, colocalized with neuropeptide Y. Irisin was detectable in CSF and in paraventricular neurons. Maternal serum irisin was lower in nonobese pregnant women after adjusting for BMI and a number of metabolic parameters. These studies indicate that irisin may have a central role in metabolism in addition to the known peripheral role. Further studies investigating the central action of irisin in human metabolic disease are required.
Assuntos
Adiposidade/fisiologia , Diabetes Gestacional/metabolismo , Fibronectinas/metabolismo , Hipotálamo/metabolismo , Obesidade/metabolismo , Adulto , Biomarcadores/líquido cefalorraquidiano , Biomarcadores/metabolismo , Diabetes Gestacional/líquido cefalorraquidiano , Feminino , Fibronectinas/líquido cefalorraquidiano , Humanos , Neurônios/metabolismo , Neuropeptídeo Y/metabolismo , Obesidade/líquido cefalorraquidiano , GravidezRESUMO
Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation syndrome (ROHHADS) is a rare, but potentially lethal, pediatric disorder. To date, nearly 80 patients have been reported in the literature; however, the etiopathogenesis is still unclear and debated. Both genetic and paraneoplastic or immune-mediated causes have been supposed to be involved in this syndrome. Nonetheless, at this time, a diagnostic biomarker is not available and diagnosis is based exclusively on clinical criteria. Aiming to establish the immune-mediated pathogenesis, we report 2 children with a clinical picture consistent with ROHHADS and whose cerebrospinal fluid analysis disclosed an intrathecal synthesis of oligoclonal bands. Even if many aspects remain to be explained, this finding suggests that ROHHADS could share similar pathogenetic mechanisms with other immune-mediated central nervous system disorders, and even more important, it might pave the way to a therapeutic chance for these patients by means of immunotherapy.
Assuntos
Doenças do Sistema Nervoso Autônomo/líquido cefalorraquidiano , Doenças Hipotalâmicas/líquido cefalorraquidiano , Hipoventilação/líquido cefalorraquidiano , Obesidade/líquido cefalorraquidiano , Bandas Oligoclonais/líquido cefalorraquidiano , Pré-Escolar , Feminino , Humanos , Masculino , SíndromeRESUMO
Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD) is a rare and complex pediatric syndrome, essentially caused by dysfunction of 3 vital systems regulating endocrine, respiratory, and autonomic nervous system functioning. The clinical spectrum of ROHHAD is broad, but sleep/wake disorders have received relatively little attention so far, although the central hypothalamic dysfunction would make the occurrence of sleep symptoms likely. In this case report, we expand the phenotype of ROHHAD with a number of striking sleep symptoms that together can be classified as a secondary form of narcolepsy. We present a 7-year-old girl with ROHHAD who displayed the classic features of narcolepsy with cataplexy: excessive daytime sleepiness with daytime naps, visual hallucinations, and partial cataplexy reflected in intermittent loss of facial muscle tone. Nocturnal polysomnography revealed sleep fragmentation and a sleep-onset REM period characteristic for narcolepsy. The diagnosis was confirmed by showing an absence of hypocretin-1 in the cerebrospinal fluid. We discuss potential pathophysiological implications as well as symptomatic treatment options.
Assuntos
Doenças Hipotalâmicas/diagnóstico , Hipoventilação/diagnóstico , Peptídeos e Proteínas de Sinalização Intracelular/deficiência , Narcolepsia/diagnóstico , Neuropeptídeos/deficiência , Obesidade/diagnóstico , Criança , Diagnóstico Diferencial , Evolução Fatal , Feminino , Parada Cardíaca/etiologia , Humanos , Doenças Hipotalâmicas/líquido cefalorraquidiano , Peptídeos e Proteínas de Sinalização Intracelular/líquido cefalorraquidiano , Neuropeptídeos/líquido cefalorraquidiano , Obesidade/líquido cefalorraquidiano , Orexinas , Polissonografia , Puberdade Precoce/líquido cefalorraquidiano , Puberdade Precoce/diagnóstico , Apneia do Sono Tipo Central/líquido cefalorraquidiano , Apneia do Sono Tipo Central/diagnóstico , Transtornos do Sono-Vigília/líquido cefalorraquidiano , Transtornos do Sono-Vigília/diagnósticoRESUMO
Diet-induced obesity (DIO) reduces the ability of centrally administered insulin to reduce feeding behavior and also reduces the transport of insulin from the periphery to the central nervous system (CNS). The current study was designed to determine whether reversal of high-fat DIO restores the anorexic efficacy of central insulin and whether this is accompanied by restoration of the compromised insulin transport. Adult male Long-Evans rats were initially maintained on either a low-fat chow diet (LFD) or a high-fat diet (HFD). After 22 weeks, half of the animals on the HFD were changed to the LFD, whereas the other half continued on the HFD for an additional 8 weeks, such that there were 3 groups: 1) a LFD control group (Con; n = 18), 2) a HFD-fed, DIO group (n = 17), and 3) a HFD to LFD, DIO-reversal group (DIO-rev; n = 18). The DIO reversal resulted in a significant reduction of body weight and epididymal fat weight relative to the DIO group. Acute central insulin administration (8 mU) reduced food intake and caused weight loss in Con and DIO-rev but not DIO rats. Fasting cerebrospinal fluid insulin was higher in DIO than Con animals. However, after a peripheral bolus injection of insulin, cerebrospinal fluid insulin increased in Con and DIO-rev rats but not in the DIO group. These data provide support for previous reports that DIO inhibits both the central effects of insulin and insulin's transport to the CNS. Importantly, DIO-rev restored sensitivity to the effects of central insulin on food intake and insulin transport into the CNS.